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Information in practice
Creative use of existing clinical and health outcomes data
to assess NHS performance in England: Part 1—
performance indicators closely linked to clinical care
Azim Lakhani, James Coles, Daniel Eayres, Craig Spence, Bernard Rachet
There have been several recent calls for better data on NHS outputs and outcomes in England,
which will require new data collection with long lead times. In this, the first of two articles, the
authors show what can be done now with existing routine data across many sectors and raise issues
about assumptions and technical aspects for discussion.
A recent BMJ editorial on whether the NHS was
improving after recent government investments con-
cluded that we did not have the data to answer the ques-
tion reliably.1 The latest NHS chief executive’s report
commented on the constraints of current measures of
quality and productivity and on the need for better
measures of output and outcome extending beyond
hospital data.2 The Atkinson review of measurement of
government output and productivity also acknowl-
edged, in an interim report, the lack of measures of out-
put and outcome attributable to the NHS.3 Reports of
multidisciplinary working groups commissioned by the
Department of Health describe potential health
outcome indicators for 10 health topics, but many
require new data collection that could take several years.4
Certainly, better data on outputs and outcomes,
especially on those attributable to health service inter-
ventions, could help the NHS measure its success in its
stated aim of improving the health and wellbeing of
people in England.5 However, creative and informed
use of existing data in the interim, acknowledging
known shortcomings, may provide insights into the
extent to which outcomes are changing.6 The main
challenges are, firstly, to measure health validly and,
secondly, to make judgments about the extent to which
any improvements can be attributed to NHS interven-
tions, given other influences on health outcome.
In two articles we explore some of the technical
issues involved and make practical suggestions about
how best to use existing data. We have selected
examples to illustrate a range of methodological issues
covering specific sectors (hospital, primary care,
community care), multiple sectors, individual condi-
tions, multiple conditions, patients, and whole popula-
tions. This, the first, article covers indicators more
directly related to clinical care—that is, hospital case
fatality, hospital admissions for conditions treatable in
primary care, cancer survival, and stroke. Our second
article covers developmental approaches for mental
health, potentially avoidable deaths, and forecasting
coronary heart disease outcomes.7 Many other
indicators could be produced along similar lines.8
More rigorous analyses of routine data
Some indicators are based on hospital episode
statistics.9 With coverage and completeness of coding
of well over 96% for England as a whole, this is a valu-
able dataset. We have used several published
approaches8 10 11 to improve its quality:
x Removal of duplicate episodes within each financial
year
x Creation of continuous inpatient spells by linking all
contiguous episodes for individual patients covering
treatment, rehabilitation, and care across all NHS hos-
pitals in each financial year
x Assessing data quality variations between organisa-
tions and years (table 1 for 2002-3, table 1.2 on
bmj.com for other years)
x Improving case fatality measures to include deaths
after discharge by linking hospital episode statistics
with death registration data from the Office for
National Statistics (table 2)
x Considering indicator specific issues (such as how
multiple readmissions within a defined period should
be counted)
x Recoding of organisations within each continuous
inpatient spell (strategic health authority, primary care
organisation, local authority) for comparability across
years.
Full details of the specifications and methods used
for each indicator are available elsewhere8 10 11 and on
bmj.com.
Suggestions for indicators illustrating a
range of methodological issues
An improved measure of hospital case fatality
Case fatality in hospital is often cited as an outcome
measure of hospital care.12 13 It is assumed that better
NHS interventions will reduce hospital deaths within a
defined period after admission by ensuring timely
Extra technical details of the methods described appear on
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detection of disease, timely hospital admission, and
higher quality of treatment and care in hospital.
The BMJ “Dr Foster’s case notes” argued for an
indicator comprising just 80 diagnoses that cover
about 80% of 30 day mortality in hospital.12 This
excludes some conditions that are amenable to
care—such as hernias, cholelithiasis, and some types of
pneumonia—and which, though individually responsi-
ble for small numbers of deaths, could collectively
make a material difference to a hospital’s case fatality
rates compared with those of others. Also, the Dr
Foster indicator includes case fatality from cancer,
which can be misleading because the proportions of
cancer patients coming into hospital for palliative care
will vary with location, type of hospital, and over time
depending on the availability of alternative care
facilities. In addition, hospital case fatality within a
defined period is an incomplete measure, as many
deaths occur after transfer to another hospital or after
final discharge. By linking hospital episode statistics
data with death registration data it is possible to
include all deaths.
Table 1 Completeness and quality of data from hospital episode statistics (values are numbers unless stated otherwise)
Values for England financial year
2002-3 (range for strategic health
authorities)
Total finished and unfinished consultant episodes available for analysis after removal of duplicates* 13 427 090
Total finished consultant episodes available for analysis after removal of duplicates† 12 692 451
Independent count of hospital activity (finished consultant episodes) submitted by NHS trusts 12 632 619
Surplus records submitted to hospital episode statistics 59 832
Continuous inpatient spells created from finished and unfinished episodes 12 016 995
% of finished consultant episodes ending in death in hospital with primary diagnosis missing or invalid 2.6 (0.3-6.0)
% of all finished consultant episodes used for hospital case fatality indicator with primary diagnosis missing or invalid 2.1 (0.2-6.1)
% of all episodes used for hospital case fatality indicator with missing or invalid codes in at least one hospital episode
statistics field used for the indicator (similar figures for the stroke admissions and primary care indicators)
2.9 (0.6-8.4)
% of all episodes used for stroke case fatality and timely discharge indicators with missing or invalid codes in at least one
hospital episode statistics field used for the indicator (similar figures for the readmissions indicator)
3.6 (0.7-9.3)
% of all episodes used for patterns of mental health care indicator with missing or invalid codes in at least one hospital
episode statistics field used for the indicator
3.0 (0.6-8.5)
*Includes regular day and night episodes.
†Excludes regular day and night episodes.
Table 2 Values for suggested NHS performance indicators in England over five financial years
Outcome
Financial year
Trend for average annual
improvement*
1998-9 1999-2000 2000-1 2001-2 2002-3 (95% CI) % R2 P value
Hospital case fatality†
No of deaths 180 485 174 089 161 745 161 690 162 722
Death rate/100 000:
England, indirectly standardised to 2001-2 1996.3 1932.0 1819.1 1796.3 1769.8 (1761.2 to 1778.4) 3.1 0.926 0.009
England, indirectly standardised to 1998-9 1995.9 1929.2 1811.6 1789.9 1764.7 (1756.1 to 1773.3) 3.2 0.919 0.010
England, directly standardised to pooled years
1998-2003
1986.0 1918.9 1805.2 1782.9 1757.2 (1749.5 to 1764.9) 3.1 0.923 0.009
SHA minimum (2001-2 as standard) 1796.1 1754.3 1649.2 1575.9 1609.4 (1554.0 to 1666.4)
SHA maximum (2001-2 as standard) 2202.8 2101.1 2003.0 1991.2 1959.9 (1905.1 to 2016.0)
% of deaths in admitting hospital 84.4 84.6 84.6 85.1 85.4
% of deaths after transfer 1.7 1.9 2.0 2.0 2.2
% of deaths after discharge 13.9 13.5 13.5 12.9 12.4
Admissions for acute conditions treatable in primary care‡
No of admissions 189 410 185 413 180 987 179 183 181 550
Admission rate/100 000:
England 387.7 379.2 369.4 364.7 368.7 (367.0 to 370.4) 1.4 0.792 0.043
SHA minimum 280.4 274.0 269.2 251.7 251.6 (244.6 to 258.7)
SHA maximum 537.3 521.1 496.8 493.7 504.0 (490.8 to 517.5)
Admissions for chronic conditions treatable in primary care§
No of admissions 93 786 91 473 86 122 85 847 85 254
Admission rate/100 000:
England 192.0 186.9 175.8 174.6 173.3 (172.1 to 174.5) 2.7 0.878 0.019
SHA minimum 143.5 139.9 126.8 121.9 124.4 (119.6 to 129.3)
SHA maximum 263.2 253.3 237.9 232.8 229.3 (220.5 to 238.4)
SHA=Strategic health authorities (as at April 2003).
*Fitting a linear trend to log transformed rates.
†Deaths in hospital and after discharge among patients of all ages, between 0 and 29 days (inclusive) of hospital admission. Rates indirectly standardised for age, sex, method of admission, and
primary diagnosis per 100 000 continuous inpatient spells (excluding those with a diagnosis of cancer anywhere in the spell), standardised to 1998-9, 2001-2, or 1998-2003 as indicated. (Data
sources: hospital episode statistics, Office for National Statistics.)
‡Emergency admissions for ear, nose, and throat conditions, kidney or urinary tract infections, and heart failure. Rates indirectly standardised for age and sex per 100 000 people of all ages,
standardised to 2000-1. (Data source: hospital episode statistics, ICD-10 codes (for primary diagnosis) H66.0-H66.4, H66.9, J02.0, J02.8, J02.9, J03.0, J03.8, J03.9, J04.0, J06.0, J06.8, J06.9,
J31.0-J31.2, N15.9, N39.0, N30.0, I50.0, I50.1, I50.9 or I11.)
§Emergency admissions for asthma and diabetes. Rates indirectly standardised for age and sex per 100 000 people of all ages, standardised to 2000-1. (Data source: hospital episode statistics,
ICD-10 codes (for primary diagnosis) J45-J46, E10-E14.)
See bmj.com for further details on indicators.
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We developed a generic case fatality indicator cov-
ering all deaths within 30 days of admission to hospital
for any reason excluding cancer. The rate was
standardised by age (19 groups), sex (two groups),
admission method (elective or non-elective), and
primary diagnosis (51 elective and 219 non-elective
groups). We defined the diagnosis groups using the
ICD-10 (international classification of diseases, 10th
revision) codes at chapter, sub-chapter, or three digit
level when the case fatality rate was significantly differ-
ent from that of the next higher level in two
consecutive financial years and there were at least 50
deaths in each year (see bmj.com for details). Table 2
shows significant falling trends over five financial
years and significant geographical variation within
each year.
Measures reflecting primary care
Table 2 shows significant falling trends and significant
geographical variation in potentially avoidable hospital
admissions for acute and chronic conditions that
could, in most instances, be managed in primary care.10
This picture is encouraging.
The Office for National Statistics has used cluster
analyses to create an area classification for grouping
local authorities that are most similar in terms of 42
demographic, socioeconomic, housing, and other
Census 2001 variables.14 Figure 1 presents rates of hos-
pital admissions for these local authority groups for
acute conditions usually managed in primary care. It
shows substantial variation between “like” local
authorities. This suggests that there may be factors
other than population and environmental ones that
may influence these admission rates, such as quality of
primary care. However, there may be other factors out-
side the control of primary care providers, such as
accessibility of accident and emergency and outpatient
facilities and hospital admission policies.
Cancer survival
There have been several recent commitments to
improving cancer services and outcomes (such as the
NHS cancer plan).5 The overall target for reducing the
disease burden is expressed in terms of mortality, but
mortality trends reflect both the incidence of cancer
and the survival of cancer patients. Mortality is not the
best indicator to measure the progress of health
services in treating those with the disease. A better
indicator for this is the relative survival rate after diag-
nosis.
Relative survival for a particular period is an
estimate of the proportion of cancer patients who sur-
vive their disease after adjustment for death from other
causes (that is, the ratio of the survival rate observed to
that which would have been expected if cancer patients
had had the same overall mortality as the general
population). Relative survival can be directly standard-
ised for age to take account of variation in survival by
age and changes in the age distribution of cancer
patients over time or between areas.
At the time of their publication, cancer survival
indicators will reflect the impact of past as well as cur-
rent health care, over the five years from diagnosis.
Trends and geographical variation may be due to sev-
eral factors including the quality of primary care, the
speed of referral, and the quality of treatment services.
They may also be a proxy for other factors not readily
measured, such as the local population’s level of
understanding of cancer symptoms and what to do
about them, variations in the extent of disease at diag-
nosis (stage) and in the histology and grade of
tumours, and artefacts in the data.
Table 3 shows significant improving trends at the
England level and non-significant geographical varia-
tion in five year survival for patients with cancers of the
breast or prostate during 1993-7. Figure 2 shows five
year survival trends for eight major cancers (bladder,
breast, cervix, colon, lung, oesophagus, prostate, and
stomach) diagnosed over the periods 1971-5 to 1986-
9015 and 1991-5 to 1996-916 and followed up to the end
of 2001 (follow up for the final period is incomplete).
Survival from cancers of the breast (women) and colon
(both sexes) shows steady improvement over three
decades. Prostate cancer survival increased much faster
in the 1990s than in the previous two decades; this may
reflect the increasing use of prostate specific antigen
testing, which results in earlier diagnosis (and therefore
greater recorded survival) of a large proportion of
tumours.
Stomach cancer survival remains low, and in abso-
lute terms the increase in survival has been small. Rela-
tively speaking, however, the chances of surviving have
tripled for both men and women over the period. Both
male and female bladder cancer survival seems to be
levelling off. Indeed, the survival for women fell slightly
between 1991-5 and 1996-9. Survival for cervical can-
cer also fell slightly between these two periods. For
cancers of the oesophagus and lung, survival rates are
low and absolute improvements are small.
The suitability of cancer survival as a measure of
improvement of health services varies with the type of
cancer. For cancers such as lung cancer, where survival
is poor, the indicator may not be sensitive enough to
determine real improvements from one period to
another nor real variations between geographical
Ra
te
/1
00
 0
00
 (9
5%
 C
I)
0
200
400
600
800
1000
England
Ma
nu
fac
tur
ing
 to
wn
s
Ind
us
tria
l h
int
erl
an
ds
Co
as
tal
 an
d c
ou
ntr
ys
ide
Pr
os
pe
rin
g s
ou
the
rn 
En
gla
nd
Ne
w 
an
d g
row
ing
 to
wn
s
Pr
os
pe
rin
g s
ma
lle
r to
wn
s
Lo
nd
on
 co
sm
op
oli
tan
Lo
nd
on
 ce
ntr
e
Lo
nd
on
 su
bu
rbs
Th
riv
ing
 Lo
nd
on
 pe
rip
he
ry
Ce
ntr
es
 w
ith
 in
du
str
y
Re
gio
na
l c
en
tre
s
En
gla
nd
ONS area group average
Local authority value
ONS area group for local authorities
Fig 1 Local health authorities’ rates of emergency admissions to hospital for acute conditions
usually managed in primary care, indirectly standardised for age and sex, per 100 000 people
of all ages, financial year 2002-3. Local authorities are grouped by Office for National
Statistics (ONS) area classification. (Data from hospital episode statistics)
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areas. Also, for such cancers, services may be focused
on prevention and palliation rather than cure: survival
does not measure this aspect of patient care. For other
cancers—such as of the colon, prostate, and breast—
early diagnosis tools or effective treatments are
available, and significant improvements in survival
have been observed.
Comprehensive measurement reflecting a variety
of perspectives
The greatest proportion of healthcare expenditure on
high blood pressure and stroke is on stroke treatment,
rehabilitation, and long term care,17 even though stroke
is, to a certain extent, preventable through health serv-
ice intervention. For assessing what is being achieved in
this clinical area, single indicators in isolation would
present an incomplete picture of a complex reality.
Table 4 contains a set of indicators that provide a more
detailed insight as follows:
x A significant rising trend in obesity. This implies an
increasing future risk of high blood pressure and
stroke, and hence of future NHS resource use. Obesity
is only partially amenable to healthcare interventions
x No significant changes in high blood pressure, an
indicator of risk of future stroke
x A significant rising trend in levels of treated and
controlled high blood pressure (the single most
important known NHS preventive intervention for
stroke), although there is still plenty of room for
improvement. In 2002, of 10 653 adults of all ages with
blood pressure measurements in the Health Survey for
England, 25% had untreated high blood pressure and
8% had high blood pressure that was treated but not
controlled18
x A significant falling trend in population levels of
hospitalisation for stroke. In the absence of suitable
community based data, emergency hospital admissions
may be used as a rough proxy for incidence, although
not everyone with a stroke is admitted to hospital, and
this will vary geographically. New guidelines on the
development of dedicated stroke units were expected
to lead to an increase in hospital admission rates, so a
falling trend may indicate falling incidence
x A non-significant rising trend in emergency
readmissions after discharge from hospital after
treatment for stroke. Some of these readmissions may
be due to potentially avoidable adverse events
x A significant falling trend in case fatality after a
stroke
x A significant rising trend in timely discharge to
usual place of residence. The timing is a proxy for
completed treatment and rehabilitation, and a dis-
charge to a place other than the usual place of
residence might indicate an important life change and
poor outcome
x A significant falling trend in population mortality
from stroke. It is suggested that 70% of stroke mortal-
ity represents failure of secondary prevention and
treatment by healthcare organisations, and 30 % repre-
sents failure of primary prevention, some but not all of
which is amenable to treatment.19 There is some over-
lap with case fatality.
These indicators provide a mixed picture. The
NHS is improving on several fronts, but many of its
resources are used for managing problems that are
to some extent preventable. How should hospital
activity in managing stroke (and its commensurate
expenditure) be used in assessing NHS productivity?
Table 3 Values for suggested performance indicators for cancer survival in England
Outcome
Year of cancer diagnosis Trend for average annual improvement*
1993 1994 1995 1996 1997 (95% CI) % R2 P value
Breast cancer survival
No of diagnoses 26 122 26 382 27 144 27 748 29 460
Five year survival rate (%)†:
England 72.0 74.0 74.9 75.8 77.3 (75.8 to 78.8) 1.7 0.978 0.001
GOR minimum 67.6 69.0 69.6 67.6 72.8 (65.5 to 80.1)
GOR maximum 74.2 78.4 76.4 77.4 79.4 (75.2 to 83.6)
Prostate cancer survival
No of diagnoses 14 382 15 965 16 538 16 731 16 580
Five year survival rate (%)†:
England 52.5 57.3 60.4 63.3 64.5 (62.4 to 66.5) 5.2 0.943 0.006
GOR minimum 47.1 42.1 46.8 45.1 51.6 (42.1 to 61.1)
GOR maximum 56.3 62.6 66.9 71.6 69.4 (63.7 to 75.0)
GOR=Government office region.
*Fitting a linear trend to log transformed rates.
†Age standardised five year relative survival rates for women aged 15-99 years (for breast cancer) and men aged 15-99 (for prostate cancer). Range for government
office regions excludes the north east region because of known data problems.
Sources of data: Office for National Statistics. See bmj.com for further details on indicators.
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Table 4 Values for suggested NHS performance indicators for high blood pressure in England over five financial or calendar years
Outcome
Financial or calendar year Trend for average annual improvement*
Year 1 Year 2 Year 3 Year 4 Year 5 (95% CI) % R2 P value
Obesity†
No of adults obese 2 756 1 364 1 456 3 035 1 439
Obesity rate (%):
England 19.0 19.5 20.7 21.7 22.1 (21.0 to 23.1) −4.1 0.972 0.002
GOR minimum 16.9 16.4 17.8 18.9 17.1 (14.2 to 20.0)
GOR maximum 22.3 22.9 24.2 25.2 26.2 (22.8 to 29.6)
High blood pressure‡
No of adults with HBP 4 339 NM 2 024 3 993 1 710
HBP rate (%):
England 35.4 34.5 35.3 33.3 (32.1 to 34.4) 1.2 0.509 0.287
GOR minimum 32.9 31.7 31.8 30.4 (26.9 to 34.0)
GOR maximum 39.5 39.2 40.9 36.6 (32.9 to 40.3)
Treated and controlled high blood pressure§
No of adults with controlled HBP 322 NM 194 417 226
Controlled HBP rate (%):
England 6.1 7.8 8.3 9.8 (8.2 to 11.3) 12.3 0.989 0.006
SHA minimum 4.3 3.6 6.5 5.3 (2.0 to 8.6)
SHA maximum 9.0 14.4 13.4 16.1 (7.8 to 24.3)
Hospitalisation for stroke (proxy for incidence)¶
No of admissions 69 478 67 785 65 027 64 884 66 038
Admission rate/100 000:
England 144.3 139.9 132.7 130.7 131.6 (130.6 to 132.6) 2.5 0.8 0.027
SHA minimum 113.9 95.3 97.2 93.2 101.4 (96.6 to 106.4)
SHA maximum 182.5 181.5 177.5 171.2 162.8 (156.3 to 169.6)
Stroke emergency readmissions**
No of readmissions 3 052 3 292 3 185 3 233 3 331
Readmission rate (%):
England 7.3 7.9 7.9 8.0 8.2 (7.9 to 8.4) −2.3 0.759 0.054
SHA minimum 5.8 6.0 6.3 6.3 6.3 (5.1 to 7.7)
SHA maximum 11.7 11.3 11.5 10.9 9.8 (8.0 to 12.0)
Stroke hospital case fatality††
No of deaths 21 125 19 392 18 035 17 509 17 671
Death rate/1000:
England 304.2 286.6 274.2 267.9 266.8 (262.8 to 270.7) 3.2 0.9 0.014
SHA minimum 264.4 253.3 220.2 230.5 212.1 (186.4 to 240.3)
SHA maximum 341.5 343.2 317.1 315.3 302.9 (284.0 to 322.8)
Timely discharge to usual place of residence after stroke admission‡‡
No of discharges 29 911 29 953 29 346 29 296 29 840
Discharge rate (%):
England 47.9 48.9 49.9 50.1 50.7 (50.2 to 51.3) 1.4 0.949 0.005
SHA minimum 41.3 42.6 44.9 46.5 46.7 (44.3 to 49.1)
SHA maximum 53.1 52.9 55.4 56.1 58.4 (55.3 to 61.8)
Stroke population mortality§§
No of deaths 59 367 57 850 54 297 54 861 55 351
Death rate/100 000:
England 73.9 71.4 66.0 65.4 65.1 (64.6 to 65.7) 3.4 0.9 0.024
SHA minimum 60.5 60.6 54.5 54.9 51.2 (48.2 to 54.3)
SHA maximum 93.3 87.2 77.8 79.4 78.8 (75.9 to 81.7)
GOR=Government office regions. NM=Not measured. HBP=High blood pressure. SHA=Strategic health authorities (as at April 2003).
*Fitting a linear trend to log transformed rates.
†Adults (aged ≥16) with body mass index >30 for calendar years 1998-2002. Rates directly standardised for age and sex using the England 2001 census non-institutional adult population
count. (Data source: health survey for England.)
‡Adults (aged ≥16) who had a valid blood pressure reading and data on drugs with a mean systolic blood pressure of ≥140 mm Hg or diastolic pressure ≥90 mm Hg or currently taking
prescribed drugs for blood pressure for calendar years 1998-2002. Rates directly standardised for age and sex using the England 2001 census non-institutional adult population count. (Data
source: health survey for England.)
§Adults taking prescribed blood pressure drugs with a blood pressure reading <140/90 mm Hg during health survey for calendar years 1998-2002. Rates (of all those with high blood pressure)
directly standardised for age using the England 2001 census non-institutional adult population count. (Data source: health survey for England.)
¶Emergency admissions of patients to hospital with stroke (primary diagnosis ICD-10 codes I61-I64) for financial years 1998-9 to 2002-3. Rates indirectly standardised for age and sex per
100 000 residents of all ages, standardised to 2000-1. The denominators are mid-year population estimates for 1998-2002. (Data source: hospital episode statistics, Office for National Statistics.)
**Emergency admissions of patients to any hospital between 0 and 27 days (inclusive) of live discharge after admission for stroke (primary diagnosis ICD-10 codes I61-I64) for financial years
1998-9 to 2002-3. Rates indirectly standardised for age and sex per 100 000 residents of all ages, standardised to 2000-1. The denominators are mid-year population estimates for 1998-2002.
(Data source: hospital episode statistics.)
††Deaths occurring in hospital and after discharge among patients of all ages between 0 and 29 days (inclusive) of an emergency admission for stroke (primary diagnosis ICD-10 codes I61-I64)
for financial years 1998-9 to 2002-3. Rates indirectly standardised for age and sex per 1000 continuous inpatient spells, standardised to 2000-1. (Data source: hospital episode statistics, Office
for National Statistics.)
‡‡Patients of all ages with an emergency admission for stroke (primary diagnosis ICD-10 codes I61-I64) who had been discharged to their preadmission accommodation within 55 days
(inclusive) of admission, for financial years 1998-9 to 2002-3. Rates indirectly standardised for age and sex as percentage of continuous inpatient spells, standardised to 2000-1. (Data source:
hospital episode statistics.)
§§Mortality from stroke (ICD-10 codes I60-I69, ICD-9 codes 430-438) among residents of all ages for 1998-2002. These ICD codes are different from those used above because, unlike hospital
episode statistics, data from Office for National Statistics do not have ICD-10 coding across all years, and there is no equivalent for ICD-10 I61-I64 in ICD-9. Years 1998 and 2000 use ICD-9,
and years 1999, 2001, and 2002 use ICD-10. Data based on ICD-9 are adjusted for equivalence to ICD-10. Rates directly standardised for age per 100 000 residents, standardised to the
European Standard Population. (Data source: Office for National Statistics.) See BMJ.com for further details on indicators.
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On one hand it reflects services provided by the
NHS, but on the other it is a consequence of past fail-
ures of the NHS. This set of indicators also raises the
issue of the time lag between resource use and its
impact. Other conditions could also be studied in this
way, by bringing together disparate but related items
of information for a critical appraisal of their
relevance and appropriateness in the assessment of
productivity.
For discussion
This article is confined to health outcome measures
and their proxies. Many other types of output, however,
could be included in an assessment of productivity. In
our second article we present further examples of indi-
cators and raise issues and assumptions that require
discussion—that is, the selection of indicators and
targets, methods, interpretation of data, and applica-
tion in productivity measurement.7
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Summary points
The extent to which recent investments in the
NHS in England have improved productivity
remains unclear because current measures do not
adequately reflect improvements in services and
outcomes achieved
Given the breadth and complexity of health care,
including the role of health services in acting as
advocates for health, measuring performance
requires a multifaceted approach
While better data are collected, which may take
years, more rigorous analysis of existing routine
data allows assessment of outputs and outcomes
across a wide range of services
Examples of such indicators that illustrate
methodological issues include improved measure
of hospital case fatality, measures reflecting
primary care, cancer survival, and comprehensive
measurement of managing high blood pressure
and stroke
Endpiece
The last Decalogue
Thou shalt have one God only; who Would be at
the expense of two?
No graven images may be
Worshipped, except the currency:
Swear not at all; for, for thy curse Thine enemy is
none the worse:
At church on Sunday to attend Will serve to
keep the world thy friend:
Honour thy parents; that is, all From whom
advancement may befall:
Thou shalt not kill; but need’st not strive Officiously to
keep alive:
Do not adultery commit;
Advantage rarely comes of it:
Thou shalt not steal; an empty feat, When it’s so
lucrative to cheat:
Bear not false witness; let the lie Have time on its
own wings to fly:
Thou shalt not covet, but tradition Approves all
forms of competition.
Arthur Clough (1819-61)
J A Hicklin, consultant rheumatologist, West Sussex
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